Clinical Trials Browser

Interventional × Hematologic Diseases × Bleomycin × Clear all

NCT01060904 2014-12-18

A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma

Phase 1 Completed

Hematologic Diseases, Hodgkin Disease, Lymphoma